p40 is a relatively new marker for the diagnosis of Squamous cell carcinoma and is particularly used for differentiating NSCLC into Adenocarcinoma & Squamous cell carcinoma. This marker is as sensitive as p63 but shows a superior specificity for Squamous cell carcinoma (96%). P40 is also expressed by 4.6% cases of Adenocarcinoma. It is negative for prostate & breast carcinoma.

  • Test Type:
  • Pre-test Information:
    Provide a copy of the Histopathology report & give brief clinical history.
  • Report Delivery:
    Sample Daily by 6 pm; Report 7 Days
  • Components: